Trevena, Inc. Named by BusinessWeek as One of the "Most Successful U.S. Startups 2008"
KING OF PRUSSIA, Pa.--(BUSINESS WIRE)-- Trevena Inc., a biotechnology company focused on discovery of a new generation of drugs that target G-protein coupled receptors, announced today that BusinessWeek magazine included Trevena in its list of most successful US startup companies of 2008. The complete list of companies is available in the December 19th, 2008 edition of BusinessWeek, and can be found at http://images.businessweek.com/ss/08/12/1217_hottest_startups/1.htm
About Trevena, Inc.
Trevena Inc. is a Philadelphia-based drug discovery company focused on developing pharmaceutical products targeting G-protein coupled receptors (GPCRs). Pharmaceutical products that target GPCRs represent over 40% of marketed drugs today. Trevena's drug discovery platform, licensed from Duke University Medical Center, is based on extensive research from the laboratories of scientists Robert J. Lefkowitz, M.D. and Howard A. Rockman, M.D. The company's drug discovery portfolio is currently focused on programs for cardiovascular and CNS indications. Trevena is privately held, and current investors are Alta Partners, Healthcare Ventures, New Enterprise Associates and Polaris Venture Partners. (www.trevenainc.com)
Source: Trevena Inc.
Released January 5, 2009